“Deucravacitinib in Plaque Psoriasis: 2-Year Laboratory Results from the Phase 3 POETYK PSO Program”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s46, https://doi.org/10.25251/skin.6.supp.46.